13F Pro quality score
Rank #2,896 of 2,968
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Incannex Healthcare Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $86.0K | $-46.9M | — |
| FY 2024 | 10-K | $12.0K | $-18.5M | — |
| FY 2021 | 20-F | $1.9M | $-11.4M | — |
| FY 2020 | 20-F | $604.9K | $-4.7M | — |
Incannex Healthcare Inc. (IXHL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IXHL at 12.3/100 on a composite quality score built from its SEC filings, placing it at rank #2,896 of 2,968 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q4 2026), Incannex Healthcare Inc. reports net income of $-2.5M, free cash flow of $3.4M. Top institutional holders of IXHL by reported 13-F value include LPL Financial, MILLENNIUM MANAGEMENT, JANE STREET GROUP, based on the most recent SEC filings. IXHL trades on the Nasdaq exchange and files with the SEC under CIK 1873875. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IXHL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Incannex Healthcare Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1873875 →